124 related articles for article (PubMed ID: 23265383)
21. Natural history of early, localized prostate cancer: a final report from three decades of follow-up.
Popiolek M; Rider JR; Andrén O; Andersson SO; Holmberg L; Adami HO; Johansson JE
Eur Urol; 2013 Mar; 63(3):428-35. PubMed ID: 23084329
[TBL] [Abstract][Full Text] [Related]
22. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
[TBL] [Abstract][Full Text] [Related]
23. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Fischer U; Dugas M; Hu J; Borkhardt A
Genes Chromosomes Cancer; 2013 Jun; 52(6):564-79. PubMed ID: 23508829
[TBL] [Abstract][Full Text] [Related]
24. Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis.
Tsujimoto Y; Takayama H; Nonomura N; Okuyama A; Aozasa K
Prostate; 2002 Sep; 52(4):279-87. PubMed ID: 12210488
[TBL] [Abstract][Full Text] [Related]
25. Genetics and genomics of prostate cancer.
Dean M; Lou H
Asian J Androl; 2013 May; 15(3):309-13. PubMed ID: 23564043
[TBL] [Abstract][Full Text] [Related]
26. Genomic hallmarks of localized, non-indolent prostate cancer.
Fraser M; Sabelnykova VY; Yamaguchi TN; Heisler LE; Livingstone J; Huang V; Shiah YJ; Yousif F; Lin X; Masella AP; Fox NS; Xie M; Prokopec SD; Berlin A; Lalonde E; Ahmed M; Trudel D; Luo X; Beck TA; Meng A; Zhang J; D'Costa A; Denroche RE; Kong H; Espiritu SM; Chua ML; Wong A; Chong T; Sam M; Johns J; Timms L; Buchner NB; Orain M; Picard V; Hovington H; Murison A; Kron K; Harding NJ; P'ng C; Houlahan KE; Chu KC; Lo B; Nguyen F; Li CH; Sun RX; de Borja R; Cooper CI; Hopkins JF; Govind SK; Fung C; Waggott D; Green J; Haider S; Chan-Seng-Yue MA; Jung E; Wang Z; Bergeron A; Dal Pra A; Lacombe L; Collins CC; Sahinalp C; Lupien M; Fleshner NE; He HH; Fradet Y; Tetu B; van der Kwast T; McPherson JD; Bristow RG; Boutros PC
Nature; 2017 Jan; 541(7637):359-364. PubMed ID: 28068672
[TBL] [Abstract][Full Text] [Related]
27. Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.
Ren S; Wei GH; Liu D; Wang L; Hou Y; Zhu S; Peng L; Zhang Q; Cheng Y; Su H; Zhou X; Zhang J; Li F; Zheng H; Zhao Z; Yin C; He Z; Gao X; Zhau HE; Chu CY; Wu JB; Collins C; Volik SV; Bell R; Huang J; Wu K; Xu D; Ye D; Yu Y; Zhu L; Qiao M; Lee HM; Yang Y; Zhu Y; Shi X; Chen R; Wang Y; Xu W; Cheng Y; Xu C; Gao X; Zhou T; Yang B; Hou J; Liu L; Zhang Z; Zhu Y; Qin C; Shao P; Pang J; Chung LWK; Xu J; Wu CL; Zhong W; Xu X; Li Y; Zhang X; Wang J; Yang H; Wang J; Huang H; Sun Y
Eur Urol; 2018 Mar; 73(3):322-339. PubMed ID: 28927585
[TBL] [Abstract][Full Text] [Related]
28. [Genetic analysis in prostate cancer].
Kobayashi T; Ogawa O
Nihon Rinsho; 2014 Dec; 72(12):2217-23. PubMed ID: 25518361
[TBL] [Abstract][Full Text] [Related]
29. Building a statistical model for predicting cancer genes.
Gorlov IP; Logothetis CJ; Fang S; Gorlova OY; Amos C
PLoS One; 2012; 7(11):e49175. PubMed ID: 23166609
[TBL] [Abstract][Full Text] [Related]
30. FunHoP analysis reveals upregulation of mitochondrial genes in prostate cancer.
Rise K; Tessem MB; Drabløs F; Rye MB
PLoS One; 2022; 17(10):e0275621. PubMed ID: 36282866
[TBL] [Abstract][Full Text] [Related]
31. A Pilot Study on the Whole Exome Sequencing of Prostate Cancer in the Indian Phenotype Reveals Distinct Polymorphisms.
Gupta A; Shukla N; Nehra M; Gupta S; Malik B; Mishra AK; Vijay M; Batra J; Lohiya NK; Sharma D; Suravajhala P
Front Genet; 2020; 11():874. PubMed ID: 33193569
[TBL] [Abstract][Full Text] [Related]
32. Towards Greater Inclusion in Cancer Genomics Studies.
Huang FW
Cancer Res; 2018 Dec; 78(24):6726-6727. PubMed ID: 30552120
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial genome analysis in biofluids for early cancer detection and monitoring.
Dakubo GD
Expert Opin Med Diagn; 2008 Mar; 2(3):263-75. PubMed ID: 23495657
[TBL] [Abstract][Full Text] [Related]
34. Point-Prostate Cancer Genomic Analysis: Routine or Research Only?
Bernard B; Flaig TW
Oncology (Williston Park); 2018 Dec; 32(12):607-9. PubMed ID: 30632132
[No Abstract] [Full Text] [Related]
35. Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?
Kelly WK; Knudsen KE
Oncology (Williston Park); 2018 Dec; 32(12):607, 630-2. PubMed ID: 30632133
[No Abstract] [Full Text] [Related]
36. The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.
Abaan OD; Polley EC; Davis SR; Zhu YJ; Bilke S; Walker RL; Pineda M; Gindin Y; Jiang Y; Reinhold WC; Holbeck SL; Simon RM; Doroshow JH; Pommier Y; Meltzer PS
Cancer Res; 2013 Jul; 73(14):4372-82. PubMed ID: 23856246
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of exome sequencing to estimate tumor burden in plasma.
Klevebring D; Neiman M; Sundling S; Eriksson L; Darai Ramqvist E; Celebioglu F; Czene K; Hall P; Egevad L; Grönberg H; Lindberg J
PLoS One; 2014; 9(8):e104417. PubMed ID: 25133800
[TBL] [Abstract][Full Text] [Related]
38. The genetic epidemiology of prostate cancer and its clinical implications.
Eeles R; Goh C; Castro E; Bancroft E; Guy M; Al Olama AA; Easton D; Kote-Jarai Z
Nat Rev Urol; 2014 Jan; 11(1):18-31. PubMed ID: 24296704
[TBL] [Abstract][Full Text] [Related]
39. Integrative clinical genomics of advanced prostate cancer.
Robinson D; Van Allen EM; Wu YM; Schultz N; Lonigro RJ; Mosquera JM; Montgomery B; Taplin ME; Pritchard CC; Attard G; Beltran H; Abida W; Bradley RK; Vinson J; Cao X; Vats P; Kunju LP; Hussain M; Feng FY; Tomlins SA; Cooney KA; Smith DC; Brennan C; Siddiqui J; Mehra R; Chen Y; Rathkopf DE; Morris MJ; Solomon SB; Durack JC; Reuter VE; Gopalan A; Gao J; Loda M; Lis RT; Bowden M; Balk SP; Gaviola G; Sougnez C; Gupta M; Yu EY; Mostaghel EA; Cheng HH; Mulcahy H; True LD; Plymate SR; Dvinge H; Ferraldeschi R; Flohr P; Miranda S; Zafeiriou Z; Tunariu N; Mateo J; Perez-Lopez R; Demichelis F; Robinson BD; Schiffman M; Nanus DM; Tagawa ST; Sigaras A; Eng KW; Elemento O; Sboner A; Heath EI; Scher HI; Pienta KJ; Kantoff P; de Bono JS; Rubin MA; Nelson PS; Garraway LA; Sawyers CL; Chinnaiyan AM
Cell; 2015 May; 161(5):1215-1228. PubMed ID: 26000489
[TBL] [Abstract][Full Text] [Related]
40. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
